51655-425 : Clemastine Fumarate 2.68 mg Oral Tablet
| NDC: | 51655-425 |
| Labeler: | Northwind Pharmaceuticals, LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Clemastine Fumarate |
| Dosage Form: | Oral Tablet |
| Application #: | ANDA073283 |
| Rev. Date: |
Appearance:
| Markings: | 93;308 |
| Shapes: |
Round |
| Colors: |
 White |
| Size (mm): | 10 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 51655-425-04: 4 TABLET IN 1 BOTTLE, DISPENSING (51655‑425‑04)
Active Ingredients:
- Clemastine Fumarate
Dosage Strength:
- 2.68 mg
Related Products:
Based on records with the same trade name.- 0093-0308 Clemastine 2 mg Oral Tablet by Teva Pharmaceuticals USA Inc
- 0093-0309 Clemastine Fumarate .5 mg/5ml Oral Syrup by Teva Pharmaceuticals USA Inc
- 0603-1096 Clemastine Fumarate .5 mg/ml Oral Syrup by Qualitest Pharmaceuticals, Inc
- 0781-1358 Clemastine Fumarate 1.34 mg (Clemastine 1 mg) Oral Tablet by Sandoz Inc
- 0781-1359 Clemastine 2 mg Oral Tablet by Sandoz Inc
- 54838-514 Clemastine Fumarate .5 mg/ml Oral Syrup by Silarx Pharmaceuticals, Inc
- 54868-5913 Clemastine Fumarate 1.34 mg (Clemastine 1 mg) Oral Tablet by Physicians Total Care, Inc.
- 62135-713 Clemastine Fumarate .67 mg/5ml Oral Syrup by Chartwell Rx, LLC
- 68151-2456 Clemastine Fumarate 1.34 mg Oral Tablet by Carilion Materials Management
- 73308-358 Clemastine Fumarate .67 mg/5ml Oral Syrup by Ayurax, LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 51655-424Next: 51655-426 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.